Skip to main content
. Author manuscript; available in PMC: 2021 Feb 26.
Published in final edited form as: Lancet. 2020 Dec 23;397(10271):334–346. doi: 10.1016/S0140-6736(20)32723-9

Table 1:

Clinical presentation of acute flaccid myelitis

Estimated frequency
Age <21 years   80–90%
Prodromal fever or viral illness   85–95%
Neurological onset to nadir <10 days 100%
Headache or neck stiffness at onset   12–60%
Asymmetric onset of weakness   65–95%
Limb weakness   85–95%
Upper limb weakness   60–85%
Flaccidity or hyporeflexia of affected limbs   95–100%
Neck, face, extraocular, or bulbar weakness   20–60%
Trunk weakness   30–70%
Requirement for mechanical ventilation   10–40%
Bladder or bowel dysfunction  5–40%
Non-specific sensory symptoms (eg, paresthesia)   10–20%
Cardiovascular autonomic dysfunction <10%
CSF pleocytosis (with testing <5 days after   85–95%
Grey-matter predominant spinal cord lesion(s) on MRI   95–100%
Brainstem lesion(s) on MRI   35–45%
Cerebral deep grey matter lesion(s) on MRI   <5%

CSF=cerebrospinal fluid.